Furthermore, fluorescence <i>in situ</i> hybridization analysis revealed that the LCNECs have a higher copy number of MET than the SCLC component while without notable difference in the copy number of HER2 and TP53. The gene discussed is MET; the disease is small cell lung carcinoma.